Nextech Invest Ltd. located in Zurich, Switzerland, was founded in 1998 as an investment advisor and management company. Nextech Invest Ltd. has raised more than USD 300 million in five investment funds and currently manages USD 220 million in four investment funds focused on oncology. Late 2006 saw the founding of Nextech II Oncology, the world's first globally active late-stage oncology fund. Nextech III Oncology and Nextech IV Oncology, building on the success of its predecessor fund, followed in 2010 and 2014, respectively. In 2017 Nextech V Oncology was launched with a focus in companies developing novel cancer therapeutics.
We deploy our expertise in oncology to invest equity in companies developing cancer therapeutics led by outstanding management teams. Each investment is supported by an eminent group of seven experts in the field of oncology.
Your eMail have been successfully registered.Close